About Cirius Therapeutics
Cirius Therapeutics is a private company based in Grand Rapids, Michigan. It has reported $49,599,975 raised in six offerings on Form D since April 2017. Its chief executive is Robert Beardsley.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 7, 2025 | Oct 8, 2025 | $800,000of $1.2M target | 22 | $36,364 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 8, 2024 | Oct 15, 2024 | $1,000,000of $1.6M target | 22 | $45,455 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 12, 2024 | Aug 20, 2024 | $1,300,000fully sold | 24 | $54,167 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| May 6, 2019 | May 14, 2019 | $7,499,972fully sold | 29 | $258K | EquityRule 506(b) | Form D ↗ |
| Aug 23, 2018 | Aug 30, 2018 | $9,000,000fully sold | 30 | $300K | EquityRule 506(b) | Form D ↗ |
| Mar 24, 2017 | Apr 10, 2017 | $30,000,003of $40.5M target | 21 | $1.4M | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $49,599,975 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cirius Therapeutics's Form D filed Oct 8, 2025.
Earlier filings also listed Mark Olesnavage (executive officer, last listed Oct 2024), Robert Zerbe, M.D. (director, last listed May 2019), Nilesh Kumar, Ph.D. (director, last listed May 2019), Elaine Sun (director, last listed May 2019), Dennis Fenton, Ph.D. (director, last listed May 2019), Daniel Estes, Ph.D. (director, last listed May 2019), Brian Farmer (executive officer, last listed May 2019) and Baltera Bob (executive officer and director, last listed May 2019).